selective drugs capable of attenuating PI3K signaling should
have significant therapeutic potential for the treatment of
inflammatory and autoimmune disorders as well as cancer
and cardiovascular diseases.1-4 Wortmannin (2) and LY294002
(3), a synthetic analogue of the flavanoid quercetin (4), are
two first-generation PI3K inhibitors that have been widely
employed as chemical genetics probes to elucidate the
biological roles of PI3K signaling. Second-generation iso-
form-selective PI3K inhibitors, whose structures appear to
be based on quercetin and LY294002, have been described
in the patent literature.5-7 It has also been reported that AS-
605240 and related thiazolidine-2,4-diones are selective
submicromolar inhibitors of PI3K γ.8
We have screened a library of marine invertebrate extracts
in a fluorescent polarization assay using human PI3K R
expressed in SF9 insect cells as part of a program designed
to find new isoform-selective PI3K inhibitors. The MeOH
extract of the sponge Aka coralliphaga collected in Dominica
showed promising activity in the assay. Bioassay-guided
fractionation of the extract identified liphagal (1), a mero-
terpenoid with an unprecedented carbon skeleton, as the only
PI3K inhibitory component. The details of the structure
elucidation, proposed biogenesis, biomimetic synthesis, and
biological activity of liphagal (1) are presented below.
were not correlated to carbon resonances in the HMQC
spectrum, were assigned to the OH protons.
Preliminary analysis of the 1H and 13C NMR spectra (Table
1, Supporting Information) revealed that liphagal (1) had both
substituted benzene and terpenoid fragments. One aliphatic
methyl doublet (δ 1.36, J ) 7.1 Hz, Me-21) and three
aliphatic methyl singlets (δ 0.91, Me-19; 0.94, Me-20; 1.28,
Me-22) were present in the 1H NMR spectrum. Resonances
that could be assigned to a pentasubstituted benzene ring (δ
107.9, C-14; 114.9, C-17; 119.2, C-12; 140.8, C-16; 145.8,
C-13; 147.2, C-15), a tetrasubstituted olefin (δ 124.4, C-10;
155.2, C-9), and a conjugated aldehyde (δ 189.7, C-18) were
observed in the 13C NMR spectrum. The benzene, olefin,
and aldehyde functionalities accounted for six of the nine
required sites of unsaturation, and the remaining three sites
had to be rings. Structural features of 1 identified from the
NMR data were similar to the structural components of
siphonodictyal B (5),9 previously isolated from specimens
of A. coralliphaga collected in Belize, suggesting that the
compounds were related.
A proton resonance at δ 7.43 (H-17) showed strong
HMBC correlations to carbon resonances at δ 140.8 (C-16),
147.2 (C-15), and 145.8 (C-13) and a weak correlation (4
bond) to 107.9 (C-14), and the aldehyde proton resonance
at δ 10.40 (H-18) showed correlations to carbon resonances
at δ 107.9 (C-14), 147.2 (C-15), and 145.8 (C-13). This set
of HMBC correlations supported the presence of a penta-
subsituted benzene ring in 1 having the same substitution
pattern found in the aromatic ring of siphonodictyal B (5).
COSY correlations identified the spin system extending from
the methylene protons at C-1 (δ 1.38 and 2.47) through to
the methylene protons at C-3 (δ 1.21 and 1.43), and starting
from H-5 (δ 1.50) through to H-8 (δ 3.16) and Me-21 (δ
1.36). HMBC correlations observed between proton reso-
nances at δ 0.91 (Me-19), 0.94 (Me-20), and 1.28 (Me-22)
and a carbon resonance at δ 53.4 (C-5); between the proton
resonances at δ 0.91 (Me-19) and 0.94 (Me-20) and the
carbon resonance at δ 41.3 (C-3); between proton resonances
at δ 1.50 (H-5) and 1.78 (H-6R) and a carbon resonance at
38.9 (C-11); between a proton resonance at δ 1.50 (H-5)
and carbon resonances at δ 39.7 (C-1) and 19.9 (C-22); and
between the proton resonance at δ 1.52 (H-6â) and the carbon
resonance at δ 34.4 (C-4) confirmed the presence of a six-
membered A ring with dimethyl substitution at C-4 and
monomethyl substitution at C-11.
Specimens of A. coralliphaga were harvested by hand
using scuba on reefs in Prince Rupert Bay, Portsmouth,
Dominica. Freshly collected sponge was frozen on site and
transported to Vancouver over dry ice. Thawed sponge was
extracted exhaustively with MeOH, and the combined MeOH
extracts were concentrated in vacuo to give an aqueous
suspension that was partitioned between H2O and EtOAc.
The H2O-soluble material, which showed strong PI3K
inhibition, was partitioned between BuOH and H2O. Frac-
tionation of the enzyme-inhibitory BuOH-soluble portion by
sequential application of Sephadex LH20 chromatography
(eluent: MeOH) and reversed-phase HPLC (eluent: 17:3
MeOH/H2O) gave a pure sample of liphagal (1).
Liphagal (1) was obtained as an optically active ([R]25
D
+12.0 (c 3.7, MeOH)) amorphous yellow solid that gave a
[M]+ ion in the HREIMS at m/z 356.1994 appropriate for a
molecular formula of C22H28O4 (calcd 356.1988), requiring
nine sites of unsaturation. The 13C NMR spectrum (Sup-
porting Information) obtained for 1 contained resonances that
could be assigned to 22 carbon atoms consistent with the
HRMS data. HMQC data showed that only 26 of the
hydrogen atoms were attached to carbon (4 × CH3, 5 × CH2,
4 × CH, 9 × C), requiring the presence of 2 OHs. Broad
The H-8 (δ 3.16) and Me-22 (1.28) resonances showed
HMBC correlations to the C-10 (δ 124.4) resonance, and
the H-7R (δ 2.12), H-8 (3.16), and Me-21 (1.36) resonances
showed correlations to the C-9 (δ 155.2) resonance, dem-
onstrating the presence of a seven-membered ring B with a
tetrasubstituted ∆9,10 olefin. An HMBC correlation observed
between the H-17 (δ 7.43) and C-10 (δ 124.4) resonances
indicated that the benzene ring carbon C-12 was bonded to
C-10. Connecting the oxygenated benzene carbon C-13 (δ
1
singlets at δ 9.29 and 10.28 in the H NMR spectrum, that
(4) Yang, L.; Williams, D. E.; Mui, A.; Ong, C.; Krystal, G.; van Soest,
R.; Andersen, R. J. Org. Lett. 2005, 7, 1073-1076.
(5) Hayakaa, M.; Kaizawa, H.; Kawaguchi, K. I.; Matsuda, K.; Ishikawa,
N.; Koizumi, T.; Yamanao, M.; Ohta, M. U.S. Patent US 6403588, 2002.
(6) Robertson, A. J.; Jackson, S.; Kenche, V.; Yaip, C. Parbaharan, H.;
Thompson, P. Int. Patent Appl. WO 0181346 A2, 2001.
(7) Sadhu, C.; Masinovsky, B.; Dick, K.; Sowell, G. C.; Staunton, D. E.
J. Immunol. 2003, 170, 2647-2654.
(8) Camps, M.; Ruckel, T.; Ji, H.; Ardissone, V.; Rintelen, F.; Shaw, J.;
Ferrandi, C.; Chabert, C.; Gillieron, C.; Francon, B.; Martin, T.; Gretener,
D.; Perrin, D.; Leroy, D.; Vitte, P.-A.; Hirsch, E.; Wymann, M. P.; Cirillo,
R.; Schwarz, M. K.; Rommel, C. Nature Med. 2005, 11, 936-943.
(9) a) Sullivan, B. W.; Faulkner, J. J. Org. Chem. 1986, 51, 4568-4573,
and b) Sullivan, B.; Djura, P.; McIntyre, D.; Faulkner, D. J. Tetrahedron
1981, 37, 979-982.
(10) Inoue, M.; Carson, M. W.; Frontier, A. J.; Danishefsky, S. J. J.
Am. Chem. Soc. 2001, 123, 1878-1889.
322
Org. Lett., Vol. 8, No. 2, 2006